This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make Billions

Benjamin Oakes' Scribe Therapeutics is developing specialized Crispr proteins for multiple diseases–and it’s got deals with Big Pharma potentially worth over $4 billion
http://dlvr.it/Ssl3Z2

Comments

Popular posts from this blog